-
The market of more than 10 billion anti-AIDS drugs has attracted pharmaceutical companies to layout
Time of Update: 2023-02-03
Another domestic anti-AIDS class 1 new drug was launched On January 5, Addi Pharmaceutical announced that the company's research and development of enomiti tablets (trade name: Fubond) was approved for marketing.
-
Mace inventory: 10 classes of 23 anti-tumor drugs that are not limited to cancer
Time of Update: 2022-10-25
According to the results of three clinical trials (NCT02122913, NCR02576431 and NCT02637687) based on the approval, the overall response rate of lalotinib treatment was 75% for patients with NTRK-positive solid tumors, including 22% complete response rate and 53% partial response rate; The duration of response was very long, with a median duration of response of 35.
-
[Food Safety Live Class] Symposium on Poultry and Egg Product Testing will start on May 10!
Time of Update: 2022-09-16
Dr. Karsten NoecklerDirector of BiosafetyGerman Federal Institute for Risk Assessment (BfR)Registration method: [I want to watch] Forum background:Foodborne illness in humans is often associated with eating meat (such as pork and chicken) or meat products that have been infected with Campylobacter, Salmonella or (monospora) Listeria .
-
BeiGene's 22 Class 1 New Drugs Are Eye-catching, Over 10 New Drugs "Going Overseas to Take the Test"
Time of Update: 2022-05-01
In terms of internationalization, BeiGene has set a record for the highest amount of authorized cooperation for a single product in China, and more than 10 self-developed innovative drugs have been clinically launched overseas, of which zanubrutinib has achieved a "zero breakthrough" .
-
incredible! Class 1 new drugs sold 10 billion, innovative drug companies "strike" the 100 billion
Time of Update: 2021-08-28
Sales of terminal protein kinase inhibitors in public medical institutions in China (unit: ten thousand yuan) Source: Mi Nei. com, China's public medical institutions terminal competition pattern With the increasing popularity of tinib drugs, Betta Pharmaceuticals has faced many challenges during the ten years when icotinib was launched on the market, including medical insurance negotiations, a 76.
-
"Innovative Drug One Brother" Outbreak This month, 10 Class 1 New Drugs Intensively Strike
Time of Update: 2021-08-27
Sales of terminal anti-tumor drugs in physical pharmacies in cities in China (unit: ten thousand yuan) Source: Mi Nei. com, China's urban physical pharmacy terminal competition pattern For newly approved innovative drugs, retail pharmacies are the main battlefield for sales .
-
Class 1 new drugs sold 10 billion yuan, innovative drug companies "attack" the 100 billion tumor drug market
Time of Update: 2021-08-27
According to data from Mi Nei. com, in 2020, the sales of terminal anti-tumor drugs in public medical institutions in China will exceed 100 billion yuan, a year-on-year increase of 9.
-
Among the top 10 domestically produced Class 1 new drug companies, these 3 are amazing!
Time of Update: 2021-06-05
0 Chinese Drug Evaluation Database 60 domestically produced Class 1 new drugs involve more than 40 companies (in terms of the group), and 10 companies including Hengrui, Hausen, BeiGene, Simcere, Beida, Gery, and Hutchison Whampoa have been approved for 2 varieties And above.
-
10 domestic 1 class of new drugs "on the market take off"! It's sunny, Hengrui, Howson is on
Time of Update: 2021-03-25
Its medical insurance effect is fully reflected in 2019, when the terminal sales of Anlotinib in China's public medical institutions exceeded 2 billion yuan, and it became a veritable large variety in the second year of its listing.
-
10 domestic 1 class of new drugs "on the market take off"! Zhengda sunny, Hengrui, Howson lit up, the three PD-1 total broke 10 billion?
Time of Update: 2021-03-24
Its medical insurance effect is fully reflected in 2019, when the terminal sales of Anlotinib in China's public medical institutions exceeded 2 billion yuan, and it became a veritable large variety in the second year of its listing.
-
10 domestic Class 1 new drugs "take off immediately after launch"
Time of Update: 2021-03-18
Its medical insurance effect is fully reflected in 2019, when the terminal sales of Anlotinib in China's public medical institutions exceeded 2 billion yuan, and it became a veritable large variety in the second year of its listing.
-
10 domestic 1 class of new drugs "on the market take off"! It's sunny, Hengrui, Howson bright...
Time of Update: 2021-03-07
Amedini is the world's second third-generation EGFR-TKI innovative drug, and the first domestic third-generation EGFR-TKI drug, approved for sale in China on March 31, 2020 for the treatment of EGFR mutation non-small cell lung cancer, the main sales channels in retail pharmacy terminals, the full-year 2020 forecast sales of more than 130 million yuan.
-
Hesco Class 1 new drugs are about to be approved for a $10 billion market for narcotic drugs
Time of Update: 2021-03-02
According to the Hesco announcement, HSK3486 emulsion is the company developed a new intravenous anesthetic drug with independent intellectual property rights, intended for surgical whole hemp induction, endoscopy sedatives / anesthesia, ICU sedation and other indications, drug registration classified as chemical drugs 1 category.
-
Hesco Class 1 new drugs are about to be approved! The market for 10 billion narcotics is cracking
Time of Update: 2021-01-07
figure 1: HSK3486 emulsion registration progress source: NMPA official website according to the Haisco announcement, HSK3486 emulsion is the company developed a new venous anesthesiology drug with independent intellectual property rights, intended for surgery full hemp induction, endoscopic sedation / anesthesia, ICU sedation and other indications, drug registration classified as chemical drugs 1 class.
-
East Sunshine Class 1 hepatitis C new drug is about to be approved! Henrui Eye's new drug is expected to be 10
Time of Update: 2021-01-06
This week look at point 1. International drug dynamics 2. East Sunshine Class 1 new hepatitis C drug "Phosphate Emitawe capsule" is about to be approved! 3. Hengrui two class 3 generic drugs declared
